Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis

Increased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The present study aimed to identify the mechanism underlying modulation of HCC development by the lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1)....

Full description

Saved in:
Bibliographic Details
Published inCancer cell international Vol. 20; no. 1; pp. 165 - 11
Main Authors Peng, Ningfu, He, Jingrong, Li, Jindu, Huang, Hao, Huang, Weiqiao, Liao, Yingyang, Zhu, Shaoliang
Format Journal Article
LanguageEnglish
Published England BioMed Central 13.05.2020
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Increased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The present study aimed to identify the mechanism underlying modulation of HCC development by the lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1). Quantitative real-time polymerase chain reaction was used to determine MALAT1 and microRNA (miR)-146a expression in HCC tissues and cell lines. Western blotting was performed to measure PI3K, Akt, and mTOR levels. Dual-luciferase reporter assay was used to validate the direct targeting and negative regulatory interaction between miR-146a and MALAT1. Cell viability, proliferation, and apoptosis were analyzed using an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, colony formation assay, and flow cytometry, respectively; autophagy was detected based on LC3B expression. MALAT1 expression was higher in HCC tissues than in normal tissues. MALAT1 upregulation promoted HCC cell proliferation, whereas MALAT1 downregulation promoted HCC apoptosis and autophagy. Moreover, effects of MALAT1 downregulation on HCC cells were abolished by miR-146a inhibition. miR-146a directly targeted the 3'-untranslated region of , and PI3K protein level was clearly decreased upon miR-146a mimic transfection. MALAT1 may modulate HCC cell proliferation, apoptosis, and autophagy via sponging miR-146a, which regulates HCC progression.
AbstractList Increased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The present study aimed to identify the mechanism underlying modulation of HCC development by the lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1). Quantitative real-time polymerase chain reaction was used to determine MALAT1 and microRNA (miR)-146a expression in HCC tissues and cell lines. Western blotting was performed to measure PI3K, Akt, and mTOR levels. Dual-luciferase reporter assay was used to validate the direct targeting and negative regulatory interaction between miR-146a and MALAT1. Cell viability, proliferation, and apoptosis were analyzed using an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, colony formation assay, and flow cytometry, respectively; autophagy was detected based on LC3B expression. MALAT1 expression was higher in HCC tissues than in normal tissues. MALAT1 upregulation promoted HCC cell proliferation, whereas MALAT1 downregulation promoted HCC apoptosis and autophagy. Moreover, effects of MALAT1 downregulation on HCC cells were abolished by miR-146a inhibition. miR-146a directly targeted the 3'-untranslated region of , and PI3K protein level was clearly decreased upon miR-146a mimic transfection. MALAT1 may modulate HCC cell proliferation, apoptosis, and autophagy via sponging miR-146a, which regulates HCC progression.
Abstract Background Increased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The present study aimed to identify the mechanism underlying modulation of HCC development by the lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1). Methods Quantitative real-time polymerase chain reaction was used to determine MALAT1 and microRNA (miR)-146a expression in HCC tissues and cell lines. Western blotting was performed to measure PI3K, Akt, and mTOR levels. Dual-luciferase reporter assay was used to validate the direct targeting and negative regulatory interaction between miR-146a and MALAT1. Cell viability, proliferation, and apoptosis were analyzed using an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, colony formation assay, and flow cytometry, respectively; autophagy was detected based on LC3B expression. Results MALAT1 expression was higher in HCC tissues than in normal tissues. MALAT1 upregulation promoted HCC cell proliferation, whereas MALAT1 downregulation promoted HCC apoptosis and autophagy. Moreover, effects of MALAT1 downregulation on HCC cells were abolished by miR-146a inhibition. miR-146a directly targeted the 3′-untranslated region of PI3K, and PI3K protein level was clearly decreased upon miR-146a mimic transfection. Conclusions MALAT1 may modulate HCC cell proliferation, apoptosis, and autophagy via sponging miR-146a, which regulates HCC progression.
Background Increased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The present study aimed to identify the mechanism underlying modulation of HCC development by the lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1). Methods Quantitative real-time polymerase chain reaction was used to determine MALAT1 and microRNA (miR)-146a expression in HCC tissues and cell lines. Western blotting was performed to measure PI3K, Akt, and mTOR levels. Dual-luciferase reporter assay was used to validate the direct targeting and negative regulatory interaction between miR-146a and MALAT1. Cell viability, proliferation, and apoptosis were analyzed using an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, colony formation assay, and flow cytometry, respectively; autophagy was detected based on LC3B expression. Results MALAT1 expression was higher in HCC tissues than in normal tissues. MALAT1 upregulation promoted HCC cell proliferation, whereas MALAT1 downregulation promoted HCC apoptosis and autophagy. Moreover, effects of MALAT1 downregulation on HCC cells were abolished by miR-146a inhibition. miR-146a directly targeted the 3′-untranslated region of PI3K, and PI3K protein level was clearly decreased upon miR-146a mimic transfection. Conclusions MALAT1 may modulate HCC cell proliferation, apoptosis, and autophagy via sponging miR-146a, which regulates HCC progression.
Increased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The present study aimed to identify the mechanism underlying modulation of HCC development by the lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1).BACKGROUNDIncreased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The present study aimed to identify the mechanism underlying modulation of HCC development by the lncRNA metastasis-associated lung adenocarcinoma transcript 1 (MALAT1).Quantitative real-time polymerase chain reaction was used to determine MALAT1 and microRNA (miR)-146a expression in HCC tissues and cell lines. Western blotting was performed to measure PI3K, Akt, and mTOR levels. Dual-luciferase reporter assay was used to validate the direct targeting and negative regulatory interaction between miR-146a and MALAT1. Cell viability, proliferation, and apoptosis were analyzed using an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, colony formation assay, and flow cytometry, respectively; autophagy was detected based on LC3B expression.METHODSQuantitative real-time polymerase chain reaction was used to determine MALAT1 and microRNA (miR)-146a expression in HCC tissues and cell lines. Western blotting was performed to measure PI3K, Akt, and mTOR levels. Dual-luciferase reporter assay was used to validate the direct targeting and negative regulatory interaction between miR-146a and MALAT1. Cell viability, proliferation, and apoptosis were analyzed using an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, colony formation assay, and flow cytometry, respectively; autophagy was detected based on LC3B expression.MALAT1 expression was higher in HCC tissues than in normal tissues. MALAT1 upregulation promoted HCC cell proliferation, whereas MALAT1 downregulation promoted HCC apoptosis and autophagy. Moreover, effects of MALAT1 downregulation on HCC cells were abolished by miR-146a inhibition. miR-146a directly targeted the 3'-untranslated region of PI3K, and PI3K protein level was clearly decreased upon miR-146a mimic transfection.RESULTSMALAT1 expression was higher in HCC tissues than in normal tissues. MALAT1 upregulation promoted HCC cell proliferation, whereas MALAT1 downregulation promoted HCC apoptosis and autophagy. Moreover, effects of MALAT1 downregulation on HCC cells were abolished by miR-146a inhibition. miR-146a directly targeted the 3'-untranslated region of PI3K, and PI3K protein level was clearly decreased upon miR-146a mimic transfection.MALAT1 may modulate HCC cell proliferation, apoptosis, and autophagy via sponging miR-146a, which regulates HCC progression.CONCLUSIONSMALAT1 may modulate HCC cell proliferation, apoptosis, and autophagy via sponging miR-146a, which regulates HCC progression.
ArticleNumber 165
Author Peng, Ningfu
Huang, Weiqiao
Li, Jindu
Liao, Yingyang
He, Jingrong
Huang, Hao
Zhu, Shaoliang
Author_xml – sequence: 1
  givenname: Ningfu
  surname: Peng
  fullname: Peng, Ningfu
– sequence: 2
  givenname: Jingrong
  surname: He
  fullname: He, Jingrong
– sequence: 3
  givenname: Jindu
  surname: Li
  fullname: Li, Jindu
– sequence: 4
  givenname: Hao
  surname: Huang
  fullname: Huang, Hao
– sequence: 5
  givenname: Weiqiao
  surname: Huang
  fullname: Huang, Weiqiao
– sequence: 6
  givenname: Yingyang
  surname: Liao
  fullname: Liao, Yingyang
– sequence: 7
  givenname: Shaoliang
  orcidid: 0000-0001-8683-4978
  surname: Zhu
  fullname: Zhu, Shaoliang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32435156$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1v1DAQhiNURD_gD3BAlrhwCeuvxMkFaVXxsWKhqFrO1sR2dl2SONgOZX8G_xinW6q2B04ejd95PJ55T7OjwQ0my14S_JaQqlwEQmtW5JjiHBPKSH79JDshXBQ5rUpxdC8-zk5DuMKYiKrEz7JjRjkrSFGeZH_WbtiiBFZO2xRdfl2iL8v1ckOQHXa2sTGguDMIRjdGF2xAMGgEU3TjDrZ75Fq0MyNEp0zXTR14pMArO7ge0JxCzR5F8FsTZ_pM6q3yLj2TE17C4tuKfV4sf8RFv7m4RPDbhufZ0xa6YF7cnmfZ9w_vN-ef8vXFx9X5cp2rohYx56ptGWaFrmiredFqUEpVVOi6IVgzVtdYU0NxVRIiRAlQl6BFDS3UolalZmfZ6sDVDq7k6G0Pfi8dWHmTcH4rwUerOiMbaAwzyhQVA94CNI3BSommLqnipiwS692BNU5Nb7QyQ_TQPYA-vBnsTm7dLykoTYubAW9uAd79nEyIsrdhnh8Mxk1BUo4LxgSpaJK-fiS9cpMf0qhmFecMFxVPqlf3O7pr5d_mk4AeBGkbIXjT3kkIlrO95MFeMtlL3thLXqei6lGRshGidfOvbPe_0r8tVtX-
CitedBy_id crossref_primary_10_3892_or_2023_8550
crossref_primary_10_1016_j_gene_2022_146791
crossref_primary_10_1080_07357907_2021_1929282
crossref_primary_10_12998_wjcc_v9_i32_9699
crossref_primary_10_1002_cbf_3785
crossref_primary_10_1016_j_jobcr_2024_12_018
crossref_primary_10_1016_j_omto_2022_03_002
crossref_primary_10_1007_s12094_024_03730_y
crossref_primary_10_1186_s12859_021_04123_6
crossref_primary_10_3389_fcell_2024_1348894
crossref_primary_10_1016_j_heliyon_2024_e34288
crossref_primary_10_1016_j_phrs_2022_106553
crossref_primary_10_1016_j_ijbiomac_2021_03_075
crossref_primary_10_3892_ijmm_2024_5456
crossref_primary_10_3390_genes13050876
crossref_primary_10_1097_CM9_0000000000003090
crossref_primary_10_1016_j_phrs_2020_105195
crossref_primary_10_1016_j_prp_2024_155769
crossref_primary_10_1038_s41417_024_00741_3
crossref_primary_10_1007_s10571_020_00991_3
crossref_primary_10_1016_j_ncrna_2024_01_015
crossref_primary_10_1016_j_humgen_2024_201370
crossref_primary_10_1177_22840265241298743
crossref_primary_10_1016_j_joim_2024_11_003
crossref_primary_10_1016_j_bbrc_2023_04_055
crossref_primary_10_1016_j_prp_2023_154604
crossref_primary_10_1177_09636897221122997
crossref_primary_10_1038_s41420_021_00497_x
crossref_primary_10_1016_j_bbcan_2021_188642
crossref_primary_10_1016_j_heliyon_2024_e37403
crossref_primary_10_1186_s12885_021_07817_5
crossref_primary_10_1016_j_bbcan_2021_188502
crossref_primary_10_1016_j_phrs_2023_106695
crossref_primary_10_1155_2021_5596712
crossref_primary_10_3389_pore_2022_1610808
crossref_primary_10_3390_jcm12020604
crossref_primary_10_1007_s11033_022_07514_x
crossref_primary_10_1155_2021_8836078
crossref_primary_10_3389_fmed_2021_734643
crossref_primary_10_3389_fonc_2024_1476684
crossref_primary_10_3390_genes15040479
crossref_primary_10_3389_fonc_2023_1048521
crossref_primary_10_3389_fcell_2024_1284934
crossref_primary_10_3390_biomedicines11102681
crossref_primary_10_1016_j_prp_2024_155303
crossref_primary_10_1371_journal_pone_0303314
crossref_primary_10_1007_s12094_022_02876_x
crossref_primary_10_1007_s13237_021_00378_9
crossref_primary_10_1016_j_clinre_2021_101736
crossref_primary_10_1016_j_actatropica_2022_106738
crossref_primary_10_1016_j_biopha_2021_111279
crossref_primary_10_1093_femsre_fuad005
crossref_primary_10_1007_s10528_023_10592_6
crossref_primary_10_3390_ijms22147261
crossref_primary_10_1002_cbin_12145
crossref_primary_10_3389_fimmu_2024_1450487
crossref_primary_10_1186_s12882_023_03438_1
crossref_primary_10_3390_cells13110918
Cites_doi 10.1038/ncomms8769
10.1038/sj.onc.1209550
10.1002/hep.24504
10.7554/eLife.05005
10.1016/j.biopha.2018.03.105
10.1016/j.biopha.2016.06.056
10.1038/srep36045
10.1016/j.coph.2008.08.004
10.1002/hep.20933
10.1158/0008-5472.CAN-16-1508
10.4238/2015.December.28.30
10.1007/s11596-015-1457-7
10.3233/CBM-160305
10.1101/gr.082701.108
10.1016/j.molmed.2014.06.005
10.1038/ncomms4393
10.1152/ajpcell.00189.2018
10.1007/s12032-009-9201-4
10.1007/s12032-011-0004-z
10.3390/ijms18071343
10.1016/j.neuroscience.2014.03.039
10.18632/oncotarget.15640
10.4161/auto.6845
10.1002/hep.29010
10.1002/2211-5463.12198
10.1158/1078-0432.CCR-04-0941
10.1158/1078-0432.CCR-11-0557
10.1002/hep.21328
10.1016/j.cellsig.2014.01.022
10.1093/abbs/gmn001
10.1038/ng.3547
10.3389/fonc.2014.00252
10.1053/j.gastro.2011.03.006
10.3390/jcm7050098
10.4238/gmr.15017433
10.1053/j.gastro.2007.04.061
10.1182/blood-2013-11-539411
10.1038/nrg1879
10.2217/fon.11.95
10.18632/oncotarget.6806
10.1159/000452582
10.1080/03008207.2018.1439480
10.1093/nar/gkx600
10.1186/1476-4598-14-5
10.4049/jimmunol.1300959
10.1038/nrc839
ContentType Journal Article
Copyright The Author(s) 2020.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2020
Copyright_xml – notice: The Author(s) 2020.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2020
DBID AAYXX
CITATION
NPM
3V.
7TM
7TO
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12935-020-01231-w
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed

Publicly Available Content Database
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1475-2867
EndPage 11
ExternalDocumentID oai_doaj_org_article_babe3ece583a4faabbe0cc7b962c4e65
PMC7222315
32435156
10_1186_s12935_020_01231_w
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: ;
  grantid: 81560460/H1602
– fundername: ;
  grantid: Z2016479
GroupedDBID ---
0R~
29B
2WC
53G
5GY
5VS
6J9
7X7
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
ISR
ITC
KQ8
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
~8M
-56
-5G
-A0
-BR
2VQ
3V.
4.4
88E
8R4
8R5
ACRMQ
ADINQ
AHSBF
C1A
C24
EJD
FRP
H13
IPNFZ
LGEZI
LOTEE
M1P
NADUK
NPM
NXXTH
PSQYO
RIG
7TM
7TO
7XB
8FK
AZQEC
DWQXO
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c597t-4cff3035d82fd45fdaccc827d9b10d33990d2e208611776aa96ad79afa979c6d3
IEDL.DBID M48
ISSN 1475-2867
IngestDate Wed Aug 27 01:31:35 EDT 2025
Thu Aug 21 18:07:12 EDT 2025
Fri Jul 11 11:38:29 EDT 2025
Mon Jun 30 03:30:23 EDT 2025
Thu Jan 02 22:54:26 EST 2025
Tue Jul 01 02:41:46 EDT 2025
Thu Apr 24 23:01:36 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords HCC
lncRNA
PI3K
Autophagy
miR
Apoptosis
Language English
License The Author(s) 2020.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c597t-4cff3035d82fd45fdaccc827d9b10d33990d2e208611776aa96ad79afa979c6d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-8683-4978
OpenAccessLink https://www.proquest.com/docview/2404430584?pq-origsite=%requestingapplication%
PMID 32435156
PQID 2404430584
PQPubID 42567
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_babe3ece583a4faabbe0cc7b962c4e65
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7222315
proquest_miscellaneous_2405337182
proquest_journals_2404430584
pubmed_primary_32435156
crossref_primary_10_1186_s12935_020_01231_w
crossref_citationtrail_10_1186_s12935_020_01231_w
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-05-13
PublicationDateYYYYMMDD 2020-05-13
PublicationDate_xml – month: 05
  year: 2020
  text: 2020-05-13
  day: 13
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Cancer cell international
PublicationTitleAlternate Cancer Cell Int
PublicationYear 2020
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References F Sahin (1231_CR47) 2004; 10
DY Peng (1231_CR26) 2015; 35
YT Lin (1231_CR30) 2017; 18
M-C Lai (1231_CR11) 2012; 29
A Fujimoto (1231_CR12) 2016; 48
TA Yap (1231_CR19) 2008; 8
L Zhou (1231_CR46) 2010; 27
M Wu (1231_CR35) 2016; 6
T Kogure (1231_CR15) 2011; 54
Y Pei (1231_CR3) 2009; 41
J Luo (1231_CR16) 2019; 316
Q Zhou (1231_CR24) 2011; 7
T Fujii (1231_CR13) 2018; 7
J Bruix (1231_CR5) 2005; 42
Z Zhang (1231_CR40) 2015; 14
A Carnero (1231_CR21) 2014; 4
JA Engelman (1231_CR18) 2006; 7
EA Toraih (1231_CR42) 2018; 102
J Wang (1231_CR34) 2014; 26
ML Burger (1231_CR48) 2014; 123
MA Avila (1231_CR1) 2006; 25
R Huang (1231_CR31) 2016; 40
P Luo (1231_CR33) 2017; 18
J Wang (1231_CR8) 2016
I Vivanco (1231_CR17) 2002; 2
M-S Lee (1231_CR20) 2015; 6
HB El-Serag (1231_CR2) 2007; 132
SM Wang (1231_CR4) 2011; 17
X Shi (1231_CR7) 2015; 14
Y Zu (1231_CR39) 2016; 6
A Villanueva (1231_CR6) 2011; 140
R Chen (1231_CR36) 2017; 45
JH Luo (1231_CR9) 2006; 44
V Agarwal (1231_CR27) 2015; 4
RC Friedman (1231_CR28) 2009; 19
Y Ding (1231_CR44) 2018; 41
L Dai (1231_CR45) 2018; 59
E Vergadi (1231_CR37) 2014; 192
X Zhang (1231_CR38) 2017; 7
M Zhao (1231_CR22) 2014; 269
C Li (1231_CR41) 2017; 8
P Malakar (1231_CR43) 2017; 77
D Li (1231_CR32) 2017; 65
W Peng (1231_CR25) 2016; 83
F Luo (1231_CR10) 2016; 7
DJ Klionsky (1231_CR29) 2008; 4
J Hayes (1231_CR14) 2014; 20
S Nakahata (1231_CR23) 2014; 5
References_xml – volume: 6
  start-page: 7769
  year: 2015
  ident: 1231_CR20
  publication-title: Nat Commun
  doi: 10.1038/ncomms8769
– volume: 25
  start-page: 3866
  year: 2006
  ident: 1231_CR1
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1209550
– volume: 54
  start-page: 1237
  year: 2011
  ident: 1231_CR15
  publication-title: Hepatology
  doi: 10.1002/hep.24504
– volume: 4
  start-page: e05005
  year: 2015
  ident: 1231_CR27
  publication-title: Elife
  doi: 10.7554/eLife.05005
– volume: 102
  start-page: 653
  year: 2018
  ident: 1231_CR42
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2018.03.105
– volume: 83
  start-page: 450
  year: 2016
  ident: 1231_CR25
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2016.06.056
– volume: 6
  start-page: 36045
  year: 2016
  ident: 1231_CR35
  publication-title: Sci Rep
  doi: 10.1038/srep36045
– volume: 8
  start-page: 393
  year: 2008
  ident: 1231_CR19
  publication-title: Curr Opin Pharmacol
  doi: 10.1016/j.coph.2008.08.004
– volume: 42
  start-page: 1208
  year: 2005
  ident: 1231_CR5
  publication-title: Hepatology
  doi: 10.1002/hep.20933
– volume: 77
  start-page: 1155
  year: 2017
  ident: 1231_CR43
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-1508
– volume: 14
  start-page: 18808
  year: 2015
  ident: 1231_CR7
  publication-title: Genet Mol Res
  doi: 10.4238/2015.December.28.30
– volume: 35
  start-page: 485
  year: 2015
  ident: 1231_CR26
  publication-title: J Huazhong Univ Sci Technol Med Sci
  doi: 10.1007/s11596-015-1457-7
– volume: 18
  start-page: 285
  year: 2017
  ident: 1231_CR33
  publication-title: Cancer Biomark
  doi: 10.3233/CBM-160305
– volume: 19
  start-page: 92
  year: 2009
  ident: 1231_CR28
  publication-title: Genome Res
  doi: 10.1101/gr.082701.108
– volume: 20
  start-page: 460
  year: 2014
  ident: 1231_CR14
  publication-title: Trends Mol Med
  doi: 10.1016/j.molmed.2014.06.005
– volume: 5
  start-page: 3393
  year: 2014
  ident: 1231_CR23
  publication-title: Nat Commun
  doi: 10.1038/ncomms4393
– volume: 316
  start-page: C299
  year: 2019
  ident: 1231_CR16
  publication-title: Am J Physiol Cell Physiol
  doi: 10.1152/ajpcell.00189.2018
– volume: 27
  start-page: 255
  year: 2010
  ident: 1231_CR46
  publication-title: Med Oncol
  doi: 10.1007/s12032-009-9201-4
– volume: 29
  start-page: 1810
  year: 2012
  ident: 1231_CR11
  publication-title: Med Oncol
  doi: 10.1007/s12032-011-0004-z
– volume: 18
  start-page: 1343
  year: 2017
  ident: 1231_CR30
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms18071343
– volume: 269
  start-page: 93
  year: 2014
  ident: 1231_CR22
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2014.03.039
– volume: 8
  start-page: 28683
  year: 2017
  ident: 1231_CR41
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.15640
– volume: 4
  start-page: 849
  year: 2008
  ident: 1231_CR29
  publication-title: Autophagy
  doi: 10.4161/auto.6845
– volume: 65
  start-page: 1612
  year: 2017
  ident: 1231_CR32
  publication-title: Hepatology
  doi: 10.1002/hep.29010
– volume: 7
  start-page: 504
  year: 2017
  ident: 1231_CR38
  publication-title: FEBS Open Bio
  doi: 10.1002/2211-5463.12198
– volume: 10
  start-page: 8421
  year: 2004
  ident: 1231_CR47
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-04-0941
– volume: 17
  start-page: 6040
  year: 2011
  ident: 1231_CR4
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-11-0557
– volume: 44
  start-page: 1012
  year: 2006
  ident: 1231_CR9
  publication-title: Hepatology
  doi: 10.1002/hep.21328
– volume: 26
  start-page: 1048
  year: 2014
  ident: 1231_CR34
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2014.01.022
– volume: 6
  start-page: 2502
  year: 2016
  ident: 1231_CR39
  publication-title: Am J Cancer Res
– volume: 41
  start-page: 1
  year: 2009
  ident: 1231_CR3
  publication-title: Acta Biochim Biophys Sin
  doi: 10.1093/abbs/gmn001
– volume: 48
  start-page: 500
  year: 2016
  ident: 1231_CR12
  publication-title: Nat Genet
  doi: 10.1038/ng.3547
– volume: 4
  start-page: 252
  year: 2014
  ident: 1231_CR21
  publication-title: Front Oncol
  doi: 10.3389/fonc.2014.00252
– volume: 140
  start-page: 1410
  year: 2011
  ident: 1231_CR6
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2011.03.006
– volume: 7
  start-page: 98
  year: 2018
  ident: 1231_CR13
  publication-title: J Clin Med
  doi: 10.3390/jcm7050098
– year: 2016
  ident: 1231_CR8
  publication-title: Genet Mol Res
  doi: 10.4238/gmr.15017433
– volume: 132
  start-page: 2557
  year: 2007
  ident: 1231_CR2
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2007.04.061
– volume: 123
  start-page: 4089
  year: 2014
  ident: 1231_CR48
  publication-title: Blood
  doi: 10.1182/blood-2013-11-539411
– volume: 7
  start-page: 606
  year: 2006
  ident: 1231_CR18
  publication-title: Nat Rev Genet
  doi: 10.1038/nrg1879
– volume: 7
  start-page: 1149
  year: 2011
  ident: 1231_CR24
  publication-title: Fut Oncol
  doi: 10.2217/fon.11.95
– volume: 7
  start-page: 5769
  year: 2016
  ident: 1231_CR10
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.6806
– volume: 40
  start-page: 707
  year: 2016
  ident: 1231_CR31
  publication-title: Cell Physiol Biochem
  doi: 10.1159/000452582
– volume: 59
  start-page: 581
  year: 2018
  ident: 1231_CR45
  publication-title: Connect Tissue Res
  doi: 10.1080/03008207.2018.1439480
– volume: 45
  start-page: 9947
  year: 2017
  ident: 1231_CR36
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkx600
– volume: 14
  start-page: 5
  year: 2015
  ident: 1231_CR40
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-14-5
– volume: 192
  start-page: 394
  year: 2014
  ident: 1231_CR37
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1300959
– volume: 2
  start-page: 489
  year: 2002
  ident: 1231_CR17
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc839
– volume: 41
  start-page: 446
  year: 2018
  ident: 1231_CR44
  publication-title: Int J Mol Med
SSID ssj0017860
Score 2.4689147
Snippet Increased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The present study aimed to...
Background Increased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The present study...
Abstract Background Increased long noncoding RNA (lncRNA) expression is characteristic to hepatocellular carcinoma (HCC) and several other neoplasms. The...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 165
SubjectTerms 1-Phosphatidylinositol 3-kinase
Adenocarcinoma
AKT protein
Apoptosis
Autophagy
Cancer therapies
Cell cycle
Cell proliferation
Cell viability
Flow cytometry
HCC
Hepatocellular carcinoma
Kinases
Liver cancer
lncRNA
Lung cancer
Medical prognosis
Metastases
Metastasis
MicroRNAs
miR
miRNA
Neoplasia
Phagocytosis
PI3K
Polymerase chain reaction
Primary Research
Proteins
TOR protein
Transcription
Transfection
Western blotting
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQJSQuiG8WCjISN2Tly3GcY0BUBdqCqq3UmzV2nG4Em6xIVmV_Bv-YmSS76iIEF66JN3E8M3lvNuM3jL1GyJIk2yvQl6yQmQ6FtjYWGFyZ06l0KqK9w6dn6vhCfrxML2-0-qKasFEeeFy4wIL1iXc-1QnICsBaHzqX2VzFTno1qJci5m2Tqen7QaZVuN0io1XQEarRTmQqwkJGI673YGhQ6_8Txfy9UvIG9BzdY3cnzsiLca732S3fPGC3xy6Sm4fs50nbXHFM411LQMTPzwp-WpwU84jXzaK2dd9xpHkcVu2qb7u649CUHNYkKQBXG95WfIGg1Lf0Jz5VpXJHDYaadgmcDnG74WPBOF2drrSkKj68jcAXIARfPiSfguJrHyznn885_Ki7R-zi6P383bGYOi0IhwlFL6SrKsSytNRxVcq0KsE5p-OszG0UlgmSmLCMfYzpD33jVQC5gjLLoYI8y50qk8fsAB_TP2Uc4z20EEsPaSWttaCcyzXyNlCYDFVqxqLtwhs3yZBTN4xvZkhHtDKjsQwaywzGMtcz9mb3m9UowvHX0W_JnruRJKA9HEC3MpNbmX-51Ywdbr3BTFHdGWQ_kiTStJyxV7vTGI9kDGh8ux7GIINGxI9n7MnoPLuZIHlNkD_iGmR7brU31f0zTb0YNL8z4nFR-ux_PNtzdiceQiEVUXLIDvrva_8CqVVvXw5R9Av5hiP0
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgCIkXxDeFgYzEG7Ly5TjOEyqIacA20NRJfYvOjtNG0KQsqUb_DP5j7pI0UIT2mjiO47vz73fO-Y6x1whZktL2CtQlI2SifaGNCQUaV2J1LK0K6Ozw6Zk6vpCf5vF82HBrhrDK3ZrYLdR5bWmP3EPkkZSeSsu36x-CqkbR39WhhMZNdotSl5FWJ_PR4QoSrfzdQRmtvIawjc4jUygW8hpxtQdGXc7-_xHNf-Ml_wKgo3vs7sAc-bQX9X12w1UP2O2-luT2Ift1UlcLjs68rQmO-PnZlJ9OT6azgJfVsjRl23AkexzW9bqtm7LhUOUcNpRYABZbXhd8idDU1rSVT7Gp3FKZoapeAadL3Gx5HzZOvVNPK4rlw9cIXAbB-_ox-uxNv7XeavblnMPPsnnELo4-zN4fi6HegrDoVrRC2qJARItzHRa5jIscrLU6TPLUBH4eIZXx89CF6ATRn14FkCrIkxQKSJPUqjx6zA7wM91TxtHqfQOhdBAX0hgDytpUI3sDhS5RoSYs2E18Zodk5FQT43vWOSVaZb2wMhRW1gkru5qwN-Mz6z4Vx7Wt35E8x5aURru7UF8ussEqkSkYFznrYh2BLACMcb61iUlVaKVT8YQd7rQhG2y7yf5o4oS9Gm-jVZIwoHL1pmuDPBpxP5ywJ73yjCNBChshi8Q5SPbUam-o-3eqctll_k6IzQXxs-uH9ZzdCTslj0UQHbKD9nLjXiB1as3Lzj5-A6roGMY
  priority: 102
  providerName: ProQuest
Title Long noncoding RNA MALAT1 inhibits the apoptosis and autophagy of hepatocellular carcinoma cell by targeting the microRNA-146a/PI3K/Akt/mTOR axis
URI https://www.ncbi.nlm.nih.gov/pubmed/32435156
https://www.proquest.com/docview/2404430584
https://www.proquest.com/docview/2405337182
https://pubmed.ncbi.nlm.nih.gov/PMC7222315
https://doaj.org/article/babe3ece583a4faabbe0cc7b962c4e65
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELf2ISRe0Phc2aiMxBsybRLHdh4QatGmAWuZqlaqeIlsJ2kj1qQ0qbb-GfzH3CVtoahCvOTBcWzHd-f7nX2-I-QNqCyOYXsZ8JJhXKo2U8a4DIRLWuVzKxy8O9zri6sR_zz2xwdkk-5oPYHFXtMO80mNFrfv7n-sPoDAv68EXolWgToL7xmjixXgFXZ3SI5BM0nMaNDjv08VpKpvDXPpM1cJublEs7eNHUVVxfPfB0L_9qX8QzldnpBHa1RJOzUbPCYHcfaEPKjzTK6ekp_XeTahYOjbHFUVHfQ7tNe57gwdmmbT1KRlQQEIUj3P52VepAXVWUT1EoMO6MmK5gmdgtoqc9zmR79VajEFUZbPNMUiala0dinH1rGlGfr5QTcMlkjduvnkfWl1vpet2fDrgOr7tHhGRpcXw49XbJ2LgVkwOUrGbZKAtvMj5SYR95NIW2uVK6PAOO3IA5jTjtzYBQMJT4GF1oHQkQx0ogMZWBF5z8kR_GZ8SiisCG2jXR5rP-HGGC2sDRQgOy3AXEpEgzibiQ_tOlA55su4DSuDRYmwJlYIxAorYoV3DfJ2-828DtPxz9pdpOe2JobYrgryxSRcSyygCBN7sY195WmeaG1M3LZWmkC4lsfCb5DzDTeEG7YNAR9xDKKmeIO83r4GiUVi6CzOl1UdwNiACdwGeVEzz3YkAG89QJgwB3KHrXaGuvsmS6dVVHCJSM_xX_5Hv2fkoVtxus8c75wclYtl_AqwVWma5FCOZZMcdy_6N4NmtUPRrIQInoPut18urySh
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELaWRQguiDeFBYwEJ2Q1D8dJDgiVx6qlD9CqK-0t2I7TRtC4bFKV_gz-CL-RmaQpFKG97TV2HCcznu-beDxDyAuALI5pexnokmI8jBwWKeUxWFyhjgKuhYtnh8cT0T_lH8-CswPyqz0Lg2GVrU2sDXVqNf4j7wLycExPFfE3y-8Mq0bh7mpbQqNRi6HZrMFlK18P3oN8X3re8Yfpuz7bVhVgGshzxbjOMrDbQRp5WcqDLJVa68gL01i5TuoDYDupZzyg-rifKaSMhUzDWGYyDmMtUh_GvUKuAvA66OyFZzsHzw0j4bQHcyLRLRFL8fwzhn4Bj2LrPfCrawT8j9j-G5_5F-Ad3yI3t0yV9hrVuk0OTHGHXGtqV27ukp8jW8xoYQttEf7oyaRHx71Rb-rSvJjnKq9KCuSSyqVdVrbMSyqLlMoVJjKQsw21GZ0DFFYWtw4wFpZqLGtU2IWkeImqDW3C1HF0HGmBsYPwGAZmV3Y_D_xht_e16i6mn06o_JGX98jppUjiPjmE1zQPCQUr4yjpcSODjCulpNA6joAtSgEuWCY6xG0_fKK3yc-xBse3pHaCIpE0wkpAWEktrGTdIa929yyb1B8X9n6L8tz1xLTd9QV7Pku2VgCYiTK-0SaIfMkzKZUyjtahioWnuRFBhxy12pBsbUmZ_NH8Dnm-awYrgMKQhbGrug_wduAZXoc8aJRnNxOgzD6wVvgG4Z5a7U11v6XI53Wm8RDZoxs8unhaz8j1_nQ8SkaDyfAxueHVCh8w1z8ih9X5yjwB2lapp_VaoeTLZS_O31F0Vlc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long+noncoding+RNA+MALAT1+inhibits+the+apoptosis+and+autophagy+of+hepatocellular+carcinoma+cell+by+targeting+the+microRNA-146a%2FPI3K%2FAkt%2FmTOR+axis&rft.jtitle=Cancer+cell+international&rft.au=Peng%2C+Ningfu&rft.au=He%2C+Jingrong&rft.au=Li%2C+Jindu&rft.au=Huang%2C+Hao&rft.date=2020-05-13&rft.issn=1475-2867&rft.eissn=1475-2867&rft.volume=20&rft.spage=165&rft_id=info:doi/10.1186%2Fs12935-020-01231-w&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-2867&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-2867&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-2867&client=summon